This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
New Strong Sell Stocks for September 25th
by Zacks Equity Research
ASO, AVD and ACLS have been added to the Zacks Rank #24 (Strong Sell) List on September 25, 2024.
American Vanguard (AVD) Q2 Earnings and Sales Miss Estimates
by Zacks Equity Research
Unfavorable market conditions weigh on American Vanguard's (AVD) top line in the second quarter.
New Strong Sell Stocks for August 12th
by Zacks Equity Research
ACI, ARCB and AVD have been added to the Zacks Rank #5 (Strong Sell) List on August 12, 2024.
American Vanguard (AVD) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
American Vanguard (AVD) delivered earnings and revenue surprises of -800% and 4.46%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Nutrien (NTR) Beats Q2 Earnings Estimates
by Zacks Equity Research
Nutrien (NTR) delivered earnings and revenue surprises of 9.86% and 6.77%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Arcadium (ALTM) Meets Q2 Earnings Estimates
by Zacks Equity Research
Arcadium (ALTM) delivered earnings and revenue surprises of 0% and 0.34%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Will American Vanguard (AVD) Report Negative Q2 Earnings? What You Should Know
by Zacks Equity Research
American Vanguard (AVD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quaker Chemical (KWR) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of -3.62% and 5%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
American Vanguard (AVD) Q1 Earnings Beat, Sales Miss Estimates
by Zacks Equity Research
American Vanguard's (AVD) U.S. crop business registers strong sales of granular soil insecticides, herbicides and cotton and peanut products in Q1.
Kinross' (KGC) Earnings and Sales Surpass Estimates in Q1
by Zacks Equity Research
Kinross' (KGC) first-quarter earnings and sales beat estimates on higher gold production.
Quaker Chemical's (KWR) Q1 Earnings Beat Estimates, Sales Lag
by Zacks Equity Research
Lower selling prices and product mix as well as reduced volumes weigh on Quaker Chemical's (KWR) top line in Q1.
Valvoline (VVV) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Valvoline (VVV) delivered earnings and revenue surprises of 2.78% and 0.05%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Huntsman's (HUN) Q1 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Huntsman's (HUN) first-quarter earnings beat estimates while sales miss on lower average selling prices.
Cabot's (CBT) Earnings Top Estimates in Q2, Revenues Lag
by Zacks Equity Research
The rise in EBIT across Cabot's (CBT) segments is partly due to higher volumes in Q2.
Westlake's (WLK) Earnings and Revenues Beat Estimates in Q1
by Zacks Equity Research
Westlake's (WLK) first-quarter earnings and sales beat estimates amid lower average selling prices.
FMC's Earnings Surpass Estimates, Revenues Lag in Q1
by Zacks Equity Research
Lower volumes due to customer inventory management actions and weaker prices hurt FMC's revenues in the first quarter.
Valmont's (VMI) Q1 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Valmont's (VMI) first-quarter earnings beat estimates and sales lag the same amid improved margins.
Scotts Miracle-Gro (SMG) Q2 Earnings & Sales Top Estimates
by Zacks Equity Research
Scotts Miracle-Gro (SMG) records lower sales in the Hawthorne segment in Q2 partly resulting from the weakness in the hydroponic industry.
ArcelorMittal's (MT) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
ArcelorMittal's (MT) first-quarter earnings and sales beat the respective estimates despite lower year-over-year steel shipments.
Ingevity's (NGVT) Earnings and Revenues Beat Estimates in Q1
by Zacks Equity Research
The decline in sales of Ingevity (NGVT) is predominantly due to the repositioning of the Performance Chemicals unit in Q1.
Century Aluminum's (CENX) Q1 Earnings & Sales Miss Estimates
by Zacks Equity Research
Lower year-over-year aluminum shipments weigh on Century Aluminum's (CENX) performance in Q1.
U.S. Steel's (X) Earnings and Revenues Lag Estimates in Q1
by Zacks Equity Research
U.S. Steel's (X) first-quarter earnings and revenues miss estimates on lower shipments.
Carpenter Technology (CRS) Q3 Earnings Top Estimates, Surge Y/Y
by Zacks Equity Research
Carpenter Technology's (CRS) Q3 results reflect its ongoing improvement in product mix as well as efforts to improve operating efficiencies.
Mosaic's (MOS) Q1 Earnings Top Estimates, Revenues Lag
by Zacks Equity Research
Mosaic's (MOS) first-quarter earnings top estimates. Sales lag the same amid lower gross margins in the Phosphate and Potash units.
Barrick (GOLD) Q1 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Barrick's (GOLD) first-quarter earnings beat estimates and sales miss amid lower gold production.